AzTrials
AzTrials

HivFP HIV SCALENCT05404958

Systems Analysis and Improvement Approach to Improve Integration of HIV Prevention and Treatment Services

A study testing Systems Analysis and Improvement Approach (SAIA) in people with Hiv, run by University of Washington at 1 site in Kenya.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

East and Southern Africa is home to 6.2% of the world's population but includes 54% of all people living with HIV (PLWH). In this region, three out of five PLWH are women, and there is a particularly high burden of HIV amongst adolescent girls and young women (AGYW). Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Hiv
What is being tested?
Systems Analysis and Improvement Approach (SAIA)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteKenya
Study dates
14 Mar 2024to 1 Oct 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • FP clinics:
  • -All FP clinics that receive County-supplied FP products will be eligible to participate.
  • FP clinic managers and staff:
  • -Any FP clinic manager that is 18 years and older is eligible to be interviewed. -These clinic managers can be male or female.
  • Kenyan public health staff:
  • Any Kenyan public health staff that is 18 years and older is eligible to be interviewed.
  • These public health staff can be male or female.

Who cannot join

  • FP clinics:
  • Any clinics that are expected to close within the next year at the time of study initiation
  • 12 facilities that participated as SAIA intervention facilities in our small-scale trial where the intervention was led by research staff.
  • FP clinic managers and staff: No exclusion criteria Kenyan public health staff: No exclusion criteria

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

McKenna Eastment contact

206-4165074

mceast@uw.edu

Kenya1 site, 1 recruiting
  • FP Clinics in Mombasa County

    Mombasa

    George Wanje

    Recruiting

Other trials in Kenya

About this study

East and Southern Africa is home to 6.2% of the world's population but includes 54% of all people living with HIV (PLWH). In this region, three out of five PLWH are women, and there is a particularly high burden of HIV amongst adolescent girls and young women (AGYW). Over half of African women use family planning (FP) services. Integration of HIV prevention and treatment with FP services holds promise for supporting progress toward the UNAIDS 95-95-95 targets for testing, treatment, and prevention. Nonetheless, integration of even basic HIV prevention and treatment services into FP clinics remains low and how best to integrate these services is still unknown. In a previous trial, the Systems Analysis and Improvement Approach (SAIA), was an effective implementation strategy for improving HIV counseling and testing in a small selection of FP clinics in Mombasa County, Kenya when delivered by research staff. SAIA incorporates a cascade analysis tool, sequential process flow mapping, and cycles of micro-intervention development, implementation, and assessment to improve a care cascade. More data is needed to understand if SAIA is effective for also improving linkage to HIV care and screening and linkage to pre-exposure prophylaxis (PrEP) in FP clinics when SAIA is delivered at scale by Kenyan public health workforce. The first objective of this study is to conduct a cluster-randomized trial evaluating the effectiveness of SAIA versus control (usual procedures with no specific intervention) for increasing HIV counseling, testing, linkage to HIV care, and screening and linkage to PrEP in new FP clients and new and returning AGYW clients. There will be a particular focus on the HIV prevention and treatment of AGYW in this study and any AGYW presenting for FP care will be prioritized. Quantitative and qualitative data will be analyzed using the RE-AIM framework to evaluate the program's Reach, Effectiveness, Adoption, Implementation, and Maintenance. To understand how SAIA could be integrated into national Ministry of Health policies and programs, activity-based costing will be conducted to estimate the budget and program impacts of SAIA, scaled to a County level, from a Ministry of Health perspective. It is hypothesized that compared to control, SAIA will be effective at increasing HIV counseling, HIV testing, linkage to HIV care, and screening and linkage to PrEP for new FP clients and all new and returning AGYW FP clients when delivered at scale by Kenyan public health staff. The implementation evaluation, costing, and budget impact analysis will establish a road map for national-level implementation, positioning Kenya as a global leader in integrating FP/HIV services.

Read the detailed description

AIM 1: To conduct a cluster-randomized trial evaluating the effectiveness of SAIA versus control (usual procedures) for increasing HIV counseling, testing, linkage to care, and screening and linkage to PrEP in new FP clients and new and returning AGYW clients. Quantitative and qualitative data will be analyzed using the RE-AIM framework (21).

1a) Reach: Proportion of intervention arm health facility clients' reached with the intervention

1b) Effectiveness: Compare the effectiveness of SAIA vs. control for increasing rates of HIV counseling, testing, linkage to care, and screening and linkage to PrEP in new FP clients and new and returning AGYW clients

1c) Adoption: Proportion of clinics adopting SAIA; adoption determinants identified using the Implementation Research Logic Model (IRLM) (22) and Organizational Readiness for Implementing Change (ORIC) scale (23)

1d) Implementation: Proportion of FP clinics implementing SAIA with high fidelity at 12 months and at 24 months; barriers and facilitators of implementation at scale by County DOH personnel will be explored using constructs from the Consolidated Framework for Implementation Research (CFIR) and the IRLM (24)

1e) Maintenance: Proportion of FP clinics maintaining SAIA at 12 months and 24 months after introduction AIM 2: To estimate the incremental cost and budget and program impacts of SAIA from a County DOH perspective. We will conduct activity-based costing and develop budget impact scenarios based on SAIA's adoption.

Conditions
Hiv
Being tested
Systems Analysis and Improvement Approach (SAIA)
Keywords
HIV prevention and treatment, Family planning, PrEP
Medical subject headings
Acquired Immunodeficiency Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Systems Analysis and Improvement Approach (SAIA)Other

    What is SAIA? It is a 5-step cycle that is repeated every 4-6 weeks for continuous quality improvement, implemented by Kenyan public health workforce and FP clinic staff, and monitored by Mombasa DOH.

    Step 1: Understanding the cascade from FP clinic enrollment to HIV testing to linkage to treatment and prevention services.

    Step 2: Use process mapping to identify modifiable bottlenecks. Step 3: Define and implement workflow adaptations to eliminate modifiable bottlenecks.

    Step 4: Monitor change in performance. Step 5: Repeat the analysis and improvement cycle (steps 1-4).

Study groups in NCT05404958
Study groupRoleWhat they receive
Intervention clinics that implement the Systems Analysis and Improvement ApproachExperimentalMombasa County public health staff will facilitate SAIA
Receives: Other: Systems Analysis and Improvement Approach (SAIA)
Usual proceduresNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effectiveness HIV counseling

    Proportion of new FP clients and all AGYW clients that are counseled for HIV out of the total new FP clients and AGYW in intervention vs control clinics

    Measured: Months 1-24

  2. Effectiveness HIV testing

    Proportion of new FP clients and all AGYW tested for HIV out of the total new FP clients and all AGYW who are eligible to be tested in intervention vs control clinics

    Measured: Months 1-24

  3. Effectiveness Linked to HIV care

    Proportion of HIV-seropositive new FP clients and all HIV-seropositive AGYW clients linked to comprehensive HIV care out of all HIV-seropositive new FP clients and all HIV-seropositive AGYW clients in intervention vs control clinics

    Measured: Months 1-24

  4. Effectiveness Screening for PrEP

    1. Proportion of new FP clients and all AGYW clients screened for PrEP out of all new FP clients and all AGYW clients who were counseled for HIV in intervention vs control clinics

    Measured: Months 1-24

  5. Effectiveness linkage to PrEP

    Proportion of new FP clients and all AGYW clients who are eligible for PrEP who are linked to PrEP out of all new FP clients and all AGYW who are eligible for PrEP in intervention vs control clinics

    Measured: 1-24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2022
  2. Study start14 Mar 2024
  3. Primary completion1 Oct 2026 (estimated)
  4. Study completion1 Oct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a cluster randomized trial enrolling family planning clinics. "Participants" are FP clinics.
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05404958
Sponsor's protocol ID
STUDY00014745
Other IDs
GRANT13455302
Acronym
FP HIV SCALE
Status last verified
Apr 2026
First submitted
24 May 2022
Last updated
4 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Systems Analysis and Improvement Approach (SAIA) in people with Hiv, run by University of Washington at 1 site in Kenya.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Kenya. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact McKenna Eastment (206-4165074, mceast@uw.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effectiveness HIV counseling (time frame: Months 1-24). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in